These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


268 related items for PubMed ID: 15782980

  • 21. How closely is Helicobacter pylori infection related to gastroduodenal lesions?
    Shimamoto C, Hirata I, Tokioka S, Takeuchi N, Hiraike Y, Katsu K.
    Hepatogastroenterology; 2006; 53(71):804-6. PubMed ID: 17086893
    [Abstract] [Full Text] [Related]

  • 22. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
    Onoda N, Katsuragi K, Maeda K, Sawada T, Wakasa K, Hirakawa K.
    Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
    [Abstract] [Full Text] [Related]

  • 23. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans.
    Isomoto H, Ueno H, Saenko VA, Mondal MS, Nishi Y, Kawano N, Ohnita K, Mizuta Y, Ohtsuru A, Yamashita S, Nakazato M, Kohno S.
    Am J Gastroenterol; 2005 Aug; 100(8):1711-20. PubMed ID: 16086706
    [Abstract] [Full Text] [Related]

  • 24. Serum pepsinogen concentration as a marker of Helicobacter pyloriinfection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels.
    Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K.
    J Gastroenterol; 2003 Aug; 38(4):332-8. PubMed ID: 12743772
    [Abstract] [Full Text] [Related]

  • 25. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels.
    Yanaoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoubayashi C, Enomoto S, Inoue I, Iguchi M, Maekita T, Ueda K, Utsunomiya H, Tamai H, Fujishiro M, Iwane M, Takeshita T, Mohara O, Ichinose M.
    Int J Cancer; 2009 Dec 01; 125(11):2697-703. PubMed ID: 19610064
    [Abstract] [Full Text] [Related]

  • 26. Immune response to CagA protein is associated with improved platelet count after Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura.
    Kodama M, Kitadai Y, Ito M, Kai H, Masuda H, Tanaka S, Yoshihara M, Fujimura K, Chayama K.
    Helicobacter; 2007 Feb 01; 12(1):36-42. PubMed ID: 17241299
    [Abstract] [Full Text] [Related]

  • 27. Morpho-functional comparisons in Helicobacter pylori-associated chronic atrophic gastritis.
    Pasechnikov VD, Chukov SZ, Kotelevets SM, Chabannaya TA.
    Rocz Akad Med Bialymst; 2005 Feb 01; 50():183-7. PubMed ID: 16358962
    [Abstract] [Full Text] [Related]

  • 28. Host factors contributing to the discovery of gastric cancer after successful eradication therapy of Helicobacter pylori: preliminary report.
    Takata S, Ito M, Yoshihara M, Tanaka S, Imagawa S, Haruma K, Chayama K.
    J Gastroenterol Hepatol; 2007 Apr 01; 22(4):571-6. PubMed ID: 17376053
    [Abstract] [Full Text] [Related]

  • 29. Relationship between ghrelin, Helicobacter pylori and gastric mucosal atrophy in hemodialysis patients.
    Ichikawa H, Sugimoto M, Sakao Y, Sahara S, Ohashi N, Kato A, Sugimoto K, Furuta T, Andoh A, Sakao T, Yasuda H.
    World J Gastroenterol; 2016 Dec 21; 22(47):10440-10449. PubMed ID: 28058025
    [Abstract] [Full Text] [Related]

  • 30. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis.
    Sitas F, Smallwood R, Jewell D, Millard PR, Newell DG, Meuwissen SG, Moses S, Zwiers A, Forman D.
    Cancer Epidemiol Biomarkers Prev; 1993 Dec 21; 2(2):119-23. PubMed ID: 8467246
    [Abstract] [Full Text] [Related]

  • 31. Helicobacter pylori status and the extent of gastric atrophy do not affect ulcer healing after endoscopic submucosal dissection.
    Kakushima N, Fujishiro M, Yahagi N, Kodashima S, Nakamura M, Omata M.
    J Gastroenterol Hepatol; 2006 Oct 21; 21(10):1586-9. PubMed ID: 16928221
    [Abstract] [Full Text] [Related]

  • 32. Helicobacter pylori eradication induces marked increase in H+/K+-adenosine triphosphatase expression without altering parietal cell number in human gastric mucosa.
    Osawa H, Kita H, Ohnishi H, Hoshino H, Mutoh H, Ishino Y, Watanabe E, Satoh K, Sugano K.
    Gut; 2006 Feb 21; 55(2):152-7. PubMed ID: 15872000
    [Abstract] [Full Text] [Related]

  • 33. Persisting chronic gastritis and elevated Helicobacter pylori antibodies after successful eradication therapy.
    Veijola L, Oksanen A, Linnala A, Sipponen P, Rautelin H.
    Helicobacter; 2007 Dec 21; 12(6):605-8. PubMed ID: 18001400
    [Abstract] [Full Text] [Related]

  • 34. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q, Ran ZH, Xiao SD.
    J Dig Dis; 2007 Feb 21; 8(1):15-22. PubMed ID: 17261130
    [Abstract] [Full Text] [Related]

  • 35. Normal serum pepsinogen I levels in adults: a population-based study with special reference to Helicobacter pylori infection and parietal cell antibodies.
    Hokkanen S, Kosunen TU, Sarna S, Miettinen A, Salomaa A, Aromaa A, Knekt P, Rautelin HI.
    Scand J Clin Lab Invest; 2005 Feb 21; 65(4):291-9. PubMed ID: 16076684
    [Abstract] [Full Text] [Related]

  • 36. Effect of Bifidobacterium bifidum fermented milk on Helicobacter pylori and serum pepsinogen levels in humans.
    Miki K, Urita Y, Ishikawa F, Iino T, Shibahara-Sone H, Akahoshi R, Mizusawa S, Nose A, Nozaki D, Hirano K, Nonaka C, Yokokura T.
    J Dairy Sci; 2007 Jun 21; 90(6):2630-40. PubMed ID: 17517703
    [Abstract] [Full Text] [Related]

  • 37. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T, Minami M, Mizuno T, Watanabe O, Ishiguro K, Ina K, Kusugami K, Nobata K, Nishiwaki T, Tsuzuki T, Shimada M, El-Omar E, Goto H.
    Helicobacter; 2005 Oct 21; 10(5):379-84. PubMed ID: 16181347
    [Abstract] [Full Text] [Related]

  • 38. Implications of corpus gastritis, atrophy and cyclooxygenase in the development of gastric erosions after curing Helicobacter pylori infection.
    Miyake K, Tatsuguchi A, Suzuki K, Ueki N, Shinji Y, Kusunoki M, Iizumi T, Hiratsuka T, Nishigaki H, Futagami S, Wada K, Tsukui T, Sakamoto C.
    Dig Liver Dis; 2005 Jun 21; 37(6):394-401. PubMed ID: 15893277
    [Abstract] [Full Text] [Related]

  • 39. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study.
    Storskrubb T, Aro P, Ronkainen J, Sipponen P, Nyhlin H, Talley NJ, Engstrand L, Stolte M, Vieth M, Walker M, Agréus L.
    Scand J Gastroenterol; 2008 Jun 21; 43(12):1448-55. PubMed ID: 18663663
    [Abstract] [Full Text] [Related]

  • 40. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori.
    Ricci C, Vakil N, Rugge M, Gatta L, Perna F, Osborn JF, Russo VM, Tampieri A, Bernabucci V, Miglioli M, Vaira D.
    Am J Gastroenterol; 2004 Oct 21; 99(10):1910-5. PubMed ID: 15447749
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.